JMP Securities Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
Colliers Securities Maintains Global Medical REIT Inc(GMRE.US) With Buy Rating, Maintains Target Price $10
Strategic Growth and Financial Stability Support Buy Rating for Global Medical REIT
BMO Capital Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating, Maintains Target Price $10
Cautious Outlook on Global Medical REIT: Hold Rating Amid Financial Misses and Leverage Concerns
Global Medical REIT Analyst Ratings
Berenberg Bank Initiates Global Medical REIT Inc(GMRE.US) With Buy Rating, Announces Target Price $11.75
Global Medical REIT Initiated With a Buy at Berenberg
A. G. P. Initiates Global Medical REIT Inc(GMRE.US) With Buy Rating, Announces Target Price $12
KeyBanc Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
JMP Securities Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
Analysts Offer Insights on Real Estate Companies: Re/Max Holdings (RMAX), Ryman (RHP) and Global Medical REIT (GMRE)
Global Medical REIT: A Hold Rating Amid Tenant Bankruptcy and Strategic Deals
Buy Rating Affirmed: Strategic Focus and Solid Financials Position Global Medical REIT for Growth
BMO Capital Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating, Maintains Target Price $10
Global Medical REIT: A Cautious Hold Amid Financial Uncertainties and Growth Concerns
Global Medical REIT Analyst Ratings
B. Riley Securities Adjusts Global Medical REIT's Price Target to $10 From $11, Keeps Buy Rating
Global Medical REIT: A Balanced Outlook With Hold Rating Amidst Tenant Challenges and Strategic Acquisitions
Analysts Offer Insights on Real Estate Companies: Global Medical REIT (GMRE) and Douglas Emmett (DEI)